0001415889-24-008316.txt : 20240318 0001415889-24-008316.hdr.sgml : 20240318 20240318174014 ACCESSION NUMBER: 0001415889-24-008316 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190910 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longpre Lara CENTRAL INDEX KEY: 0001780347 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 24760304 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4-03182024_090300.xml X0508 4 2019-09-10 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001780347 Longpre Lara C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 false true false false CHIEF DEVELOPMENT OFFICER 0 Common Stock 2019-09-10 4 P 0 965 10.64 A 105372 D Common Stock 2023-01-09 4 S 0 1003 20.6223 D 104369 D The weighted average purchase price for the transaction reported was $10.64, and the range of prices were between $10.20 and $10.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Shares sold to cover tax witholding obligations associated with the vesting of restricted stock units. /s/ Judit Ryvkin, Attorney-in-Fact 2024-03-18